Skip to content

Assessment of use of antibiotics in Covid-19 patients

Assessment of utilisation of antibiotics in COVID-19 patients: A retrospective study in a tertiary care centre in South India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039784
Enrollment
947
Registered
2022-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients of either sex having positive RTPCR of SARS-CoV-2 covid positive patients initiated on antibiotics within 48hrs of hospital admission

Exclusion criteria

Exclusion criteria: Patients with a negative RTPCR report Patients with Covid severity classified as Mild

Design outcomes

Primary

MeasureTime frame
percentage of antibiotic class used Timepoint: time point cannot be defined as it is a retrospective study and data will be collected from medical records

Secondary

MeasureTime frame
defined daily dose/1000 patient daysTimepoint: time point cannot be defined as it is a retrospective study done from the medical records department;mean duration of antibiotic therapyTimepoint: time point cannot be defined as it is a retrospective study done from the medical records department;pattern of de-escalation and discontinuation of antibiotic therapyTimepoint: time point cannot be defined as it is a retrospective study done from the medical records department

Countries

India

Contacts

Public ContactSubeesh K Viswam

Department of Pharmacy Practice, Manipal college of Pharmaceutical Sciences

subeesh.viswam@manipal.edu9448471346

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026